Josh Leisring
joshleisring.bsky.social
Josh Leisring
@joshleisring.bsky.social
Nephrologist / Hypertension Specialist in Columbus, Ohio
#Nephsky
He / him
Reposted by Josh Leisring
Ahead of #KidneyWk25, we are recruiting a hypertension fellow to the Stanford Hypertension Center for July 2026. Please come find me at ASN.

med.stanford.edu/nephrology/e...
Hypertension Fellowship
med.stanford.edu
November 5, 2025 at 7:57 AM
Reposted by Josh Leisring
Samir Parikh gives an update on lupus nephritis. #KidneyWk Looking for rapid reduction of proteinuria? Voclosporin is faster, but belimumab showed similar separation from placebo, it just takes longer due to mechanism of action.
November 5, 2025 at 3:38 PM
Reposted by Josh Leisring
BaxHTN phase 3 trial: Aldosterone dysregulation is considered a key driver of hard-to-control hypertension. Research findings on baxdrostat, a highly selective, potent aldosterone synthase inhibitor, in hard-to-control hypertension are summarized in a new Quick Take video. nej.md/3KCsQGJ
October 15, 2025 at 7:02 PM
Donate and represent!
#NephJC
October 2, 2025 at 12:36 PM
Reposted by Josh Leisring
Our @ukkidney.org guidelines here in BMC Nephrology. 💯% agree that in-unit BP should ONLY be used for determining safety of individual HD sessions and NOT long-term CV risk modification. But changing practice will be a long haul.

link.springer.com/epdf/10.1186...
Management of blood pressure in adults, children and young people on dialysis: UK kidney association clinical practice guideline
link.springer.com
September 30, 2025 at 12:03 PM
Reposted by Josh Leisring
Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>
September 29, 2025 at 7:03 PM
Reposted by Josh Leisring
#NephJC is a labor of a passionate volunteer team that believes education should be accessible, no matter where you are from in the world.

Even if editorial team donates unlimited hours of sleep, there are still costs to cover 💸 (👇 blog)

😊 Be kind, help us to #NephItForward

#Medsky #Nephsky
September 28, 2025 at 4:47 PM
Reposted by Josh Leisring
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertension/e…

-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
https://med.stanford.edu/hypertension/e…
September 25, 2025 at 8:02 AM
Reposted by Josh Leisring
It's that time of year again 🍂🍂🍂
The #NephJC Fall pledge drive.
Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky
www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive
NephJC 2025 Fall Pledge Drive — NephJC
Help keep NephJC a vital, original, and unbiased source of medical education.
www.nephjc.com
September 22, 2025 at 12:47 AM
Reposted by Josh Leisring
🚨 Survey Alert!
Standardized office BP measurements are recommended everywhere, but still underused.
We want to hear from you: what are the barriers to using them as a routine in clinical practice?

Click here to read the consent form and take the survey:
redcap.link/barriers.to....
September 22, 2025 at 4:19 PM
Reposted by Josh Leisring
My guess is at least 500 #doctors at my #hospital are on H1B visas including at least a few dozen #hospitalists, and if we lose even a handful to other countries our house of cards #healthcare system will fall apart, let alone all 500+
September 19, 2025 at 11:11 PM
Reposting this again - very relevant for #NephJC discussion on the new AHA/ACC guidelines.
To accompany the new ACC/AHA BP guidelines, a practical guide on how to test for Primary Aldosteronism: now recommended for most people with hypertension.

www.jacc.org/doi/10.1016/...
September 18, 2025 at 3:36 AM
Reposted by Josh Leisring
Reposted by Josh Leisring
To accompany the new ACC/AHA BP guidelines, a practical guide on how to test for Primary Aldosteronism: now recommended for most people with hypertension.

www.jacc.org/doi/10.1016/...
September 7, 2025 at 1:04 AM
Reposted by Josh Leisring
Confirmatory testing (aldosterone suppression testing) for primary aldosteronism: not reliable, or reproducible, for diagnosis or predicting lateralization. Sensitivity at the expense of specificity, and vice-versa. Time to simplify the process

academic.oup.com/ejendo/artic...
Discordance and shortcomings of aldosterone suppression tests in primary aldosteronism
AbstractBackground. The saline suppression test (SST) and the captopril challenge test (CCT) have traditionally been used to confirm or exclude primary ald
academic.oup.com
September 7, 2025 at 1:16 AM
Reposted by Josh Leisring
The era of ASIs is slowly dawning

www.nejm.org/doi/full/10....

(Yeah spironolactone is just as good and cheaper)

Disclosure: we recruited patients for this one
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension | NEJM
Aldosterone dysregulation plays an important pathogenic role in hard-to-control hypertension. In several studies, baxdrostat, an aldosterone synthase inhibitor, reduced the seated systolic blood pr...
www.nejm.org
August 30, 2025 at 2:39 PM
Reposted by Josh Leisring
❓What’s new in BP care?
🎥 Watch the #TargetBP webinar on the 2025 @AHAScience / @ACCinTouch Hypertension Guidelines w/ @drwanpen.bsky.social , @jordybc.bsky.social , Keith Ferdinand, & Dan Jones 👉 targetbp.org
August 28, 2025 at 6:54 PM
Reposted by Josh Leisring
The CPC from last @ahascience.bsky.social #HypertensionSessions now published in @ahajournals.bsky.social

www.ahajournals.org/doi/10.1161/...

thanks to @drjmluther.bsky.social and all the education editors for the invite

We hope it makes for an educational read!
August 20, 2025 at 6:09 PM
Reposted by Josh Leisring
More on Hydra-ANCA-zine

Four cases, and review of previous (~ 169) cases reported in the literature

academic.oup.com/ckj/article-... in @ckj-era.bsky.social

#NephSky #Hydralazine
Hydralazine-induced antineutrophil cytoplasmic antibody-associated glomerulonephritis
Antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) can lead to multi-organ failure and death [1, 2]. As an antihypertensive medica
academic.oup.com
August 18, 2025 at 10:14 AM
Commentary on expanded screening for primary aldosteronism in the new HTN guideline.

www.ahajournals.org/doi/10.1161/... 🔓
August 15, 2025 at 7:56 PM
Reposted by Josh Leisring
Nice to see new AHA HTN guidelines emphasizing albuminuria detection!
"[Urine ACR] (a test that assesses kidney health) is now recommended for all patients with high blood pressure. It was recommended as an optional test in the 2017 guideline."
newsroom.heart.org/news/new-hig...
New high blood pressure guideline emphasizes prevention, early treatment to reduce CVD risk
Guideline Highlights: Nearly half of all adults in the U.S. have high blood pressure (≥130/80 mm Hg), which is the #1 preventable risk factor for cardiovascular disease, including heart attack, stroke...
newsroom.heart.org
August 14, 2025 at 8:11 PM
Reposted by Josh Leisring
Some key changes that stood out to me (got the opportunity to help w writing these!):

1) Stronger recs for single pill combos
2) Broader recs for screening for primary aldo (now consider in anyone with stage 2 HTN — i.e., BP >=140/90)
3) Just. Say. No… to cuffless BP devices… and to EtOH

2/
No.to
August 14, 2025 at 6:10 PM